Similarly, higher FCHSD1 expression was correlated with shorter disease-specific survival (DSS) in KIRC (p=0.002), and LGG (p<0.001) patients, whereas FCHSD1 acted as a protective factor for DSS in BLCA (p=0.005) patients (Figures 7I–K). The gene discussed is FCHSD1; the disease is bladder transitional cell carcinoma.